Marker Therapeutics, Inc.
MRKR
$1.10
-$0.10-8.33%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 64.73% | -6.02% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 64.73% | -6.02% | |||
| Cost of Revenue | 48.63% | -9.30% | |||
| Gross Profit | -32.50% | 12.38% | |||
| SG&A Expenses | -25.15% | -6.26% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 24.40% | -8.33% | |||
| Operating Income | -3.98% | 9.45% | |||
| Income Before Tax | -5.27% | 8.36% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -5.27% | 8.36% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -5.27% | 8.36% | |||
| EBIT | -3.98% | 9.45% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -5.21% | 8.52% | |||
| Normalized Basic EPS | -5.20% | 8.51% | |||
| EPS Diluted | -4.00% | 7.41% | |||
| Normalized Diluted EPS | -5.20% | 8.51% | |||
| Average Basic Shares Outstanding | 0.06% | 0.18% | |||
| Average Diluted Shares Outstanding | 0.06% | 0.18% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
